Venture Global continues strong operational performance by using modular construction and smart contracting to boost LNG production and margins. The company raised its 2026 production guidance and expects an $8.9 billion EBITDA, reflecting confidence in growth and efficient project execution. Its CP2 expansion remains on schedule for the second half of 2027. Despite rapid progress, Venture Global shares trade at a discount to competitor Cheniere, offering investors a margin of safety and a continued Buy rating. Recent dividend increases and improved capital returns highlight management's positive outlook on growth, debt reduction, and capital allocation.
1606 Corp. has signed a non-binding Letter of Intent (LOI) with EthosEnergy O&M to manage operations and maintenance of its planned 55 MW power facility in Lufkin, Texas, aimed at supporting data centers and AI applications. EthosEnergy O&M brings ex...
Lexaria Bioscience Corp. announced the exercise of warrants for 453,969 shares at a reduced price of $12.92 per share, raising approximately $5.9 million in gross proceeds. The funds will support the company's working capital and general corporate pu...
Québec Innovative Materials Corp. (QIMC) has started two large-scale, non-invasive 2D seismic surveys totaling about 78 line-kilometres to explore natural hydrogen in Québec and Nova Scotia. The 36 km survey in Québec is in partnership with the Témis...
Sempra celebrated its growth by ringing the opening bell at the NYSE, highlighting its $65 billion capital plan focused on expanding and modernizing energy infrastructure in major U.S. markets, especially California and Texas. The company aims to gen...
Filament Health has shipped its patented psilocybin drug candidate PEX010 to Austin Health in Melbourne for the PSI-PHY trial, the first study to combine psilocybin-assisted physiotherapy for refractory motor functional neurological disorder (FND). S...
